|
ZC3H4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.421800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.540000E-02 |
| Normal-vs-Stage2 |
3.564400E-01 |
| Normal-vs-Stage3 |
1.818760E-03 |
| Normal-vs-Stage4 |
5.344900E-03 |
| Stage1-vs-Stage2 |
3.681000E-01 |
| Stage1-vs-Stage3 |
8.952300E-02 |
| Stage1-vs-Stage4 |
1.889840E-01 |
| Stage2-vs-Stage3 |
5.907500E-02 |
| Stage2-vs-Stage4 |
9.198000E-02 |
| Stage3-vs-Stage4 |
9.930800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.121700E-03 |
| Normal-vs-AfricanAmerican |
6.168600E-01 |
| Normal-vs-Asian |
3.435200E-01 |
| Caucasian-vs-AfricanAmerican |
1.618190E-01 |
| Caucasian-vs-Asian |
1.307240E-01 |
| AfricanAmerican-vs-Asian |
8.029400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.802400E-02 |
| Normal-vs-Female |
6.480100E-03 |
| Male-vs-Female |
4.878800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.069700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.700320E-02 |
| Normal-vs-Age(61-80Yrs) |
3.456900E-03 |
| Normal-vs-Age(81-100Yrs) |
1.537390E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.029400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.736390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.581200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.577800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.830200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.414600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.181700E-03 |
| Classical-VS-Follicular |
8.918000E-03 |
| Classical-VS-Other |
5.751800E-01 |
| Classical-VS-Normal |
1.034440E-01 |
| Tall-VS-Follicular |
3.663600E-01 |
| Tall-VS-Other |
4.136800E-01 |
| Tall-VS-Normal |
1.259660E-03 |
| Follicular-VS-Other |
7.676200E-01 |
| Follicular-VS-Normal |
2.560100E-03 |
| Other-VS-Normal |
2.740400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.634400E-02 |
| Normal-vs-N1 |
6.163400E-03 |
| N0-vs-N1 |
2.236200E-01 |
|
|
